The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.
Macromolecular permeability across the blood-nerve and blood-brain barriers.
Open accessAbstract
The permeability of insulin (Ins), nerve growth factor (NGF), albumin (Alb), transferrin (Trf), and IgG across the blood-nerve barrier (BNB) and blood-brain barrier (BBB) in normal adult rats was quantified by measuring the (permeability coefficient x surface area) product (PS) with the i.v. bolus-injection technique in the cannulated brachial vein and artery using radioiodinated proteins. The PS values of the BNB for IgG and Alb were low: 0.079 +/- 0.029 x 10(-6) and 0.101 +/- 0.088 x 10(-6) ml.g-1.s-1, (mean +/- SD, respectively). The PS values for NGF and Trf were 16.1-fold and 25.5-fold higher than for Alb. The PS for Ins across the BNB was 33.190 +/- 2.053 x 10(-6) ml.g-1.s-1--a remarkable 329-fold increase compared with Alb. The PS values of the BBB for IgG and Alb in different brain regions were all low, from 0.028 +/- 0.017 to 0.151 +/- 0.035 x 10(-6) ml.g-1.s-1 (mean +/- SD). NGF and Trf had comparable PS values from 13- to 32-fold higher than for Alb, except for the brain stem, where the PS for Trf was 66-fold higher than for Alb. The mean PS for Ins across the BBB ranged from 15.78 +/- 5.45 x 10(-6) ml.g-1.s-1 for the cortex to 22.62 +/- 7.50 x 10(-6) ml.g-1.s-1 for the brain stem--again a remarkable 105- to 390-fold increase relative to Alb. Because reliable PS measurements were obtained for all proteins tested, the BBB and BNB cannot be considered impermeable to proteins--a concept that has plagued brain- and nerve-barrier research. The low PS values for IgG and Alb indicate low rates of transfer; however, Alb, in particular, is the major protein of endoneurial and ventricular fluid, which suggests that these PS values may be significant. Ins had the highest PS values, which likely reflect the mechanism of transport across the barriers--that is, receptor-mediated transport. Because NGF and Trf had PS values 13- to 66-fold higher than for Alb, whether this reflects receptor-mediated uptake, adsorptive-mediated transcytosis, or some other mechanism is unclear. That the PS values for NGF and Trf differ from Alb and IgG clearly suggests, however, a different uptake mechanism. Finally, the remarkably high PS values for Ins across the BBB and BNB identify this protein and its putative receptor on capillary endothelial cells as a potential target for drug delivery into the central and peripheral nervous systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mAbs exhibit limited distribution to the brain, and mAb concentrations was determined to be 0.1–0.2 % and 0.02 % of the steady‐state circulating mAb concentration in rodents and cynomolgus monkey, respectively.92, 93”
From Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development (2018) · cites this paper as [92]
In the citing paper
“the PK of the anti‐Her2/CD3T cell‐dependent bispecific (TDB) antibody in rats demonstrated similar clearance and half‐life as trastuzumab.92”
From Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development (2018) · cites this paper as [92]
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,565
Transferrin receptor on endothelium of brain capillaries
Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., & Mason, D. Y. (1984) · Nature · doi:10.1038/312162a0 · Cited by 1,061
Insulin in the Brain: A Hormonal Regulator of Energy Balance*
Schwartz, M. W., Figlewicz, D. P., Baskin, D. G., Woods, S. C., & Porte, D. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-3-387 · Cited by 808
An immunohistochemical study of the nerve growth factor receptor in developing rats
Yan, Q., & Johnson, E. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-09-03481.1988 · Cited by 605
Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier
Fishman, J. B., Rubin, J. B., Handrahan, J. V., Connor, J. R., & Fine, R. E. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490180206 · Cited by 550
Taniuchi, M., Clark, H., Schweitzer, J. B., & Johnson, E. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-02-00664.1988 · Cited by 542
Receptor-Mediated Transport of Insulin Across Endothelial Cells
King, G. L., & Johnson, S. M. (1985) · Science · doi:10.1126/science.3883490 · Cited by 474
Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat
Ohno, K., Pettigrew, K. D., & Рапопорт, С. И. (1978) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1978.235.3.h299 · Cited by 454
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.
Friden, P. M., Walus, L. R., Musso, G. F., Taylor, M. A., Malfroy, B., & Starzyk, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4771 · Cited by 410
Flagged first, then by citations
1 of the 82 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 378
Yang, C., Hou, X., Feng, Q., Li, Y., Wang, X., Qin, L., & Yang, P. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-02175-0 · Cited by 24
Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large molecules
Wells, R. C., Akkapeddi, P., Chan, D., Joy, D. A., Moshkforoush, A., Chau, R., Chow, J., Cherf, G. M., Chien, E. Y. T., Clemens, A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116038 · Cited by 27
Effect of reduced flow on blood–brain barrier transport systems
Hom, S., Egleton, R. D., Huber, J. D., & Davis, T. P. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03027-4 · Cited by 24
Kim, J., Kim, J., Choi, C., Bae, J., & Choi, H. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01497-y · Cited by 25
Wahl, A.-S., Correa, D., Imobersteg, S., Maurer, M., Kaiser, J., Augath, M. A., & Schwab, M. E. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00864-z · Cited by 23
Brain Distribution of Drugs: Pharmacokinetic Considerations
Loryan, I., Hammarlund‐Udenaes, M., & Syvänen, S. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_405 · Cited by 23
Treatment of Focal Cerebral Ischemia with Liposomal Nerve Growth Factor
Luk, Y.-O., Chen, W. Y.-K., Wong, W.-J., Hu, H., Hsu, L., Chern, C.-M., Huang, K.-J., & Law, S.-L. (2004) · Drug Delivery · doi:10.1080/10717540490494104 · Cited by 23
Hodkinson, J. P., Lucas, M., Lee, M., Harrison, M., Lunn, M. P., & Chapel, H. M. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12616 · Cited by 23
Kang, Y. Y., Jung, H., Yu, G., Chong, Y., & Mok, H. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.073 · Cited by 23
Finke, J. M., & Banks, W. A. (2016) · Human Antibodies · doi:10.3233/hab-160306 · Cited by 23
Wengenack, T. M., Curran, G. L., Olson, E. E., & Poduslo, J. F. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00565-9 · Cited by 23
Self-citationTakashima, H., Tsuji, A. B., Saga, T., Yasunaga, M., Koga, Y., Kuroda, J.-I., Yano, S., Kuratsu, J., & Matsumura, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-12563-5 · Cited by 22
Heparin‐hyaluronic acid nanofibers for growth factor sequestration in spinal cord repair
Mays, E. A., Kallakuri, S., & Sundararaghavan, H. G. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36962 · Cited by 21
Swaminathan, S. K., Zhou, A. L., Ahlschwede, K. M., Curran, G. L., Lowe, V. J., Li, L., & Kandimalla, K. K. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.265876 · Cited by 25
Self-citationKochi, T., Nakamura, Y., Ma, S., Hisaoka‐Nakashima, K., Wang, D., Liu, K., Wake, H., Nishibori, M., Irifune, M., & Morioka, N. (2021) · Molecules · doi:10.3390/molecules26072035 · Cited by 22
Antinociceptive effects of dynorphin peptides in a model of inflammatory pain
Beyer, A., Schäfer, M., & Stein, C. (1997) · Pain · doi:10.1016/s0304-3959(97)03327-7 · Cited by 22
Bredack, C., Edelmann, M. R., Borroni, E., Gobbi, L. B., & Honer, M. (2022) · Pharmaceuticals · doi:10.3390/ph15121445 · Cited by 21
Autoimmune-mediated peripheral neuropathies and autoimmune pain
Klein, C. J. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63432-0.00023-2 · Cited by 21
Serum BDNF and NGF Modulation by Olive Polyphenols in Alcoholics during Withdrawal
Carito, M. C. V. (2015) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000214 · Cited by 20
Neal, J., & Gasque, P. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.08.006 · Cited by 20
Sugihara, T., Munesue, S., Yamamoto, Y., Sakurai, S., Akhter, N., Kitamura, Y., Shiba, K., Watanabe, T., Yonekura, H., Hayashi, Y., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110776 · Cited by 22
The direct effect of insulin on barosensitive neurones in the nucleus tractus solitarii of rats
Ruggeri, P., Molinari, C., Brunori, A., Cogo, C. E., Mary, D. A. S. G., Picchio, V., & Vacca, G. (2001) · Neuroreport · doi:10.1097/00001756-200112040-00023 · Cited by 20
Urayama, A., Morales, R., Niehoff, M. L., Banks, W. A., & Soto, C. A. (2011) · The FASEB Journal · doi:10.1096/fj.11-180729 · Cited by 20
The Immune System as a Therapeutic Target for Alzheimer’s Disease
Zieneldien, T., Kim, J., Sawmiller, D. R., & Cao, C. (2022) · Life · doi:10.3390/life12091440 · Cited by 19
Martínez‐Martínez, P., Molenaar, P. C., Losen, M. H., Stevens, J., Baets, M. H. D., Szöke, A., Honnorat, J., Tamouza, R., Leboyer, M., van Os, J., et al. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00181 · Cited by 19
Chowdhury, E. A., Alqahtani, F., Bhattacharya, R., Mehvar, R., & Bickel, U. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.12.007 · Cited by 19
Meister, S. W., Hjelm, L. C., Dannemeyer, M., Tegel, H., Lindberg, H., Ståhl, S., & Löfblom, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082999 · Cited by 21
Gosselaar, P. H., Van‐Dijk, A. J. G., GAST, G. C. D., Polito, L., Bolognesi, A., Vooijs, W. C., Verheul, A. F. M., Krouwer, H. G. J., & Marx, J. J. M. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1061.x · Cited by 19
Bhattamisra, S. K., Shin, L. Y., Saad, H. I. B. M., Rao, V., Candasamy, M., Pandey, M., & Choudhury, H. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200518102130 · Cited by 18
Dang, X., Williams, S. B., Devanathan, S., Franco, A., Fu, L., Bernstein, P. R., Walters, D., & Dorn, G. W. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00163 · Cited by 18
Yamamoto, M., Okui, N., Tatebe, M., Shinohara, T., & Hirata, H. (2011) · Journal of Anatomy · doi:10.1111/j.1469-7580.2011.01341.x · Cited by 18
A novel method for measuring hydraulic conductivity at the human blood-nerve barrier in vitro
Helton, E. S., Palladino, S. P., & Ubogu, E. E. (2016) · Microvascular Research · doi:10.1016/j.mvr.2016.08.005 · Cited by 18
Olthof, M. G. L., Kempen, D. H. R., Liu, X., Dadsetan, M., Tryfonidou, M. A., Yaszemski, M. J., Dhert, W. J. A., & Lu, L. (2019) · Tissue Engineering Part A · doi:10.1089/ten.tea.2018.0140 · Cited by 18
Li, W., Jia, H., Wang, Z., Zhai, F., Sun, G.-D., Ma, D., Liu, G., Li, C., & Wang, Y. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731420980136 · Cited by 17
Custers, M., Wouters, Y., Jaspers, T., Bundel, D. D., Dewilde, M., Eeckhaut, A. V., & Smolders, I. J. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.338803 · Cited by 19
Yoo, S. I., Yang, M., Brender, J., Vivekanandan, S., Sun, K., Joo, N. E., Jeong, S., Ramamoorthy, A., & Kotov, N. A. (2011) · Angewandte Chemie · doi:10.1002/ange.201007824 · Cited by 17
Liu, P., Thomson, B. R., Khalatyan, N., Feng, L., Liu, X., Savas, J. N., Quaggin, S. E., & Jin, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807982115 · Cited by 17
Serum NGF levels in children and adolescents with either Williams syndrome or Down syndrome
Calamandrei, G., Alleva, E., Cirulli, F., Queyras, A., Volterra, V., Capirci, O., Vicari, S., Giannotti, A., Turrini, P., & Aloe, L. (2000) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162200001389 · Cited by 17
Alelwani, W., Elmorsy, E. M., Kattan, S. W., Babteen, N. A., Alnajeebi, A. M., Al-Ghafari, A. B., & Carter, W. G. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.08.006 · Cited by 16
Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders
Niazi, S. K., Mariam, Z., & Magoola, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126683 · Cited by 16
Position on zinc delivery to olfactory nerves in intranasal insulin phase I–III clinical trials
Hamidovic, A. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.08.011 · Cited by 16
Lin, C., Wang, T.-H., How, S.-C., Bednáriková, Z., Fedunová, D., Gažová, Z., Wu, J. W., & Wang, S. S. ‐. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.09.104 · Cited by 16
New Insights into the Susceptibility of Immunocompetent Mice to Usutu Virus
Benzarti, E., Sarlet, M., Franssen, M., Desmecht, D. J.-M., Schmidt‐Chanasit, J., & Garigliany, M. (2020) · Viruses · doi:10.3390/v12020189 · Cited by 16
Capsoni, S., Marinelli, S., Ceci, M., Vignone, D., Amato, G., Malerba, F., Paoletti, F., Meli, G., Viegi, A., Pavone, F., et al. (2012) · PLoS ONE · doi:10.1371/annotation/97b6c799-1ebc-4e7b-8f86-47c1130dc00e · Cited by 16
Metabolite transport across central nervous system barriers
Carstens, G., Verbeek, M. M., Rohlwink, U. K., Figaji, A., Brake, L. T., & van Laarhoven, A. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241241908 · Cited by 17
Assessing central nervous system drug delivery
Hammarlund‐Udenaes, M., & Loryan, I. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2462767 · Cited by 17
Neuro-ophthalmology and the anti-GQ1b antibody syndromes
Saul, R. F. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0055-0 · Cited by 15
A new technology for increasing therapeutic protein levels in the brain over extended periods
Nakano, R., Takagi‐Maeda, S., Ito, Y., Kishimoto, S., Osato, T., Noguchi, K., Kurihara-Suda, K., & Takahashi, N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214404 · Cited by 15
Bobula, B., Sowa, J. E., & Hess, G. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.08.011 · Cited by 14
Gauden, V., Hu, D. ‐., Kurokawa, T., Sarker, M. H., & Fraser, P. A. (2007) · Microcirculation · doi:10.1080/10739680701410421 · Cited by 14
Anti-Amyloid-β-Mediated Positron Emission Tomography Imaging in Alzheimer's Disease Mouse Brains
McLean, D., Cooke, M. J., Wang, Y., Green, D., Fraser, P. E., George‐Hyslop, P. S., & Shoichet, M. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051958 · Cited by 14
Bridging the blood-brain barrier: strategies to improve delivery of biologics to tumors in the brain
Gampa, G., Vadlakonda, R., Stefanich, E. G., Kamath, A. V., Sadekar, S., & Shivva, V. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00760-2 · Cited by 13
Ellerman, D. A. (2024) · BioDrugs · doi:10.1007/s40259-024-00691-0 · Cited by 13
Sano, H., Sano, Y., Ishiguchi, E., Shimizu, F., Omoto, M., Maeda, T., Nishihara, H., Takeshita, Y., Takahashi, S., Oishi, M., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25772 · Cited by 13
Iwasaki, T., Kanda, T., & Mizusawa, H. (1999) · PubMed · doi:10.11501/3191195 · Cited by 13
Alteration of Vascular Endothelial Cadherin in Alzheimer’s Disease Patient and Mouse ModelPreprint
Lee, D., Cho, S., Lim, H. J., Seok, J., Jo, C., Jo, S. A., Park, M. H., Han, C., Kowall, N. W., Ryu, H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/430140 · Cited by 15
Zhou, A. L., Swaminathan, S. K., Salian, V. S., Wang, L., Curran, G. L., Min, H.-K. P., Lowe, V. J., & Kandimalla, K. K. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00784 · Cited by 12
Self-citationSalian, V. S., Tang, X., Thompson, K. J., Curran, G. L., Lowe, V. J., Li, L., Kalari, K. R., & Kandimalla, K. K. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.124.002280 · Cited by 14
Self-citationThe effect of calcium modulating agents on peripheral nerve recovery after crush
Yan, J., Zhang, L., Agresti, M., LoGiudice, J. A., Yan, Y., Wang, Z., Sanger, J. R., & Matloub, H. S. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.04.013 · Cited by 12
Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin
Zhou, A. L., Sharda, N., Sarma, V., Ahlschwede, K. M., Curran, G. L., Tang, X., Poduslo, J. F., Kalari, K. R., Lowe, V. J., & Kandimalla, K. K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215128 · Cited by 11
Self-citationSchengrund, C., & Mummert, C. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09681.x · Cited by 12
Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity
Petrella, C., Ciotti, M. T., Nisticò, R., Piccinin, S., Calissano, P., Capsoni, S., Mercanti, D., Cavallaro, S., Possenti, R., & Severini, C. (2020) · Cells · doi:10.3390/cells9122651 · Cited by 11
Isolation and Properties of Endothelial Cells Forming the Blood-Nerve Barrier
Sano, Y., & Kanda, T. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-938-3_21 · Cited by 11
Domínguez, S. L., Hegde, G. V., Hanson, J. E., Xiang, H., Mandikian, D., Boswell, C. A., Chiu, C., Wu, Y., Tsai, S. P., Fleck, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26492-4 · Cited by 12
Developmental profile of serum nerve growth factor levels in Rett complex.
Calamandrei, G., Aloe, L., Hajek, J., & Zappella, M. (2001) · PubMed · Cited by 11
Reinholz, M. M., Haggard, J. J., Curran, G. L., & Poduslo, J. F. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7117 · Cited by 11
Self-citationAge-related changes in barrier function in mouse brain
Ueno, M., Akiguchi, I., Hosokawa, M., Shinnou, M., Sakamoto, H., Takemura, M., & Higuchi, K. (1997) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(97)00022-8 · Cited by 11
Lu, W. L., Kuang, H., Gu, J., Hu, X., Chen, B., & Fan, Y. (2023) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2023.102671 · Cited by 10
Francesco, V. D., Chua, A. J. K., Bleier, B. S., & Amiji, M. M. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c18679 · Cited by 11
Alam, D., Khan, T., Naaz, F., Ahmad, T., Shahid, M., Hassan, M. I., Islam, A., & Sardar, M. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.126746 · Cited by 11
Development of Positron Emission Tomography Radiotracers for Imaging α-Synuclein Aggregates
Guo, X., Xiang, J., Ye, K., & Zhang, Z. (2025) · Cells · doi:10.3390/cells14120907 · Cited by 11
ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience
de Lucas, Á. G., Lamminmäki, U., & Lopez‐Picon, F. R. (2023) · Biomolecules · doi:10.3390/biom13010164 · Cited by 11
Breakdown of blood‐nerve barrier in immune‐mediated neuropathy
Shimizu, F., & Kanda, T. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12200 · Cited by 10
Blood Supply and Microcirculation of the Peripheral Nerve
Prahm, C., Heinzel, J. C., & Kolbenschlag, J. (2022) · Reference series in biomedical engineering · doi:10.1007/978-3-030-21052-6_21 · Cited by 10
Advances and Challenges in Gene Therapy for Alzheimer’s Disease
Morroni, F., & Caccamo, A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230783 · Cited by 11
Evaluation of Tetrazine Tracers for Pretargeted Imaging within the Central Nervous System
Edelmann, M. R., Bredack, C., Belli, S., Mohr, P., Imhoff, M., Reggiani, F., Kusznir, E. A., Rufer, A. C., Holt, D. P., Valentine, H., et al. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00385 · Cited by 9
Spiekman, I. A. C., Geurts, B. S., Zeverijn, L. J., de Wit, G. F., van der Noort, V., Roepman, P., de Leng, W. W. J., Jansen, A. M. L., Küsters, B., Beerepoot, L. V., et al. (2023) · The Oncologist · doi:10.1093/oncolo/oyad320 · Cited by 10
Translational strategies in peripheral neuroinflammation and neurovascular repair
Ubogu, E. E. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0039-4 · Cited by 9
Antonelli, A., Bracci‐Laudiero, L., & Aloe, L. (2003) · Gerontology · doi:10.1159/000069170 · Cited by 9
Capillary diffusion capacity and tissue distribution of pancreatic procolipase in rat
Rippe, C., Rippe, B., & Erlanson‐Albertsson, C. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.5.g1179 · Cited by 9
A Site-Specific MiniAp4–Trastuzumab Conjugate Prevents Brain Metastasis
Masmudi‐Martín, M., Oller‐Salvia, B., Perea, M., Teixidò, M., Valiente, M., Giralt, E., & Sánchez‐Navarro, M. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c01091 · Cited by 9
Kasai, N., Adachi, M., & Yamano, K. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1803-2 · Cited by 7
Olthof, M. G. L., Tryfonidou, M. A., Dadsetan, M., Dhert, W. J. A., Yaszemski, M. J., Kempen, D. H. R., & Lu, L. (2018) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2018.0024 · Cited by 8
Danilova, R. A., Moskvityna, T. A., Obukhova, M. F., Belopolskaya, M. V., & Ашмарин, И. П. (1999) · Neurochemical Research · doi:10.1023/a:1020764504462 · Cited by 8
Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation
Bauer-Smith, H., Sudol, A. S. L., Beers, S. A., & Crispin, M. (2023) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2023.130448 · Cited by 10
Vega, M., Hansen, H. H., Jensen, C. S., Alexiou, E., Madsen, M. R., Wichern, F., Kristiansen, M. S., Skytte, J. L., Salinas, C. G., Sotty, F., et al. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00737-7 · Cited by 10
Toxicologic Neuropathology of Novel Biotherapeutics
Bangari, D. S., Lanigan, L. G., Cramer, S. D., Grieves, J. L., Meisner, R., Rogers, A. B., Galbreath, E. J., & Bolon, B. N. (2023) · Toxicologic Pathology · doi:10.1177/01926233241230542 · Cited by 7
Brunner, R. C. (2014) · International Journal of Physical Medicine & Rehabilitation · doi:10.4172/2329-9096.1000202 · Cited by 7
Unexpected amount of blood-borne protein enters the young brain
Munji, R. N., & Daneman, R. (2020) · Nature · doi:10.1038/d41586-020-01791-x · Cited by 7
Li, F., Li, D., Liu, J., Tang, S., Yan, J., Li, H., Wan, Z., Wang, L. Y., & Yan, X. (2023) · Journal of Pain · doi:10.1016/j.jpain.2023.01.003 · Cited by 7
Fibroblast growth factor decreases locomotor activity in rats
Guaza, C., Garcia-Andrés, C., Sandi, C., Muñoz‐Willery, I., Cuevas, P., & Giménez‐Gallego, G. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00247-3 · Cited by 7
Peripheral nerve barrier and its implications for drug delivery
Liu, H., & Sahi, J. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104435 · Cited by 6
Francesco, V. D., Chua, A. J. K., Davoudi, E., Kim, J., Bleier, B. S., & Amiji, M. M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.056 · Cited by 6
Herzig, R., Wang‐Leandro, A., Steffen, F., Matiasek, K., & Beckmann, K. M. (2021) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16112 · Cited by 6
Usefulness of sural nerve biopsy in the genomic era
Kanda, T. (2009) · Neuropathology · doi:10.1111/j.1440-1789.2009.01009.x · Cited by 6
Smith, J. R., & Winkelstein, B. A. (2017) · Journal of Neurosurgery Spine · doi:10.3171/2016.9.spine16501 · Cited by 6
Effect of Peripheral Insulin Administration on Phosphorylation of Tau in the Brain
Jiang, Y., Li, L., Dai, C., Zhou, R., Gong, C., Iqbal, K., Gu, J., & Liu, F. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200147 · Cited by 6
Mokarizadeh, A., Esmaeili, P., Soraya, H., Hassanzadeh, K., Jalili, A., Abdi, M., & Faryabi, M. R. (2015) · Journal of Medical Hypotheses and Ideas · doi:10.1016/j.jmhi.2015.02.002 · Cited by 6
Abuse liability assessment for biologic drugs – All molecules are not created equal
de Zafra, C. L. Z., Markgraf, C. G., Compton, D. M., & Hudzik, T. J. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.11.019 · Cited by 5
Blood–neural barrier: Overview and latest progress
Sano, Y., & Kanda, T. (2013) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12021 · Cited by 6
Metadata
- Authors
- Poduslo, J. F., Curran, G. L., & Berg, C. T.
- Affiliations
- Mayo Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1994-06-07
- Volume
- 91
- Issue
- 12
- Pages
- 5705-5709
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC44065
- OpenAlex
- W2071079524
- Cited by
- 377
- References
- 82
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 18 · 2023: 24 · 2022: 16 · 2021: 16 · 2020: 32 · 2019: 16 · 2018: 20 · 2017: 16 · 2016: 14 · 2015: 10 · 2014: 9 · 2013: 12 · 2012: 19
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Keywords
- blood-nerve barrier, blood-brain barrier, macromolecule permeability, protein permeability, insulin, nerve growth factor, transferrin, IgG, albumin, permeability coefficient, brain regions, brainstem, ventricular fluid, radioiodinated proteins, rats
- MeSH terms
- Albumins, Animals, Blood-Brain Barrier, Brain, Endocytosis, Insulin, Male, Metabolic Clearance Rate, Nerve Growth Factors, Permeability, Transferrin, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review